AbCellera Biologics Inc vs AMC ENTERTAINMENT HOLDINGS, INC. — how do they compare? AbCellera Biologics Inc trades at $8.98 (market cap $2.99B), while AMC ENTERTAINMENT HOLDINGS, INC. trades at $2.39 (market cap $2.14B). The key difference: AbCellera Biologics Inc is the larger of the two by market cap, and AMC ENTERTAINMENT HOLDINGS, INC. pays a 0.11% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | AMC | |
|---|---|---|
Market Cap | $2.99B | $2.14B |
Sector | Health | Media |
52-Week High | $9.76 | $3.15 |
52-Week Low | $2.78 | $0.95 |
Enterprise Value | $2.58B | $9.08B |
Dividend Yield | — | 0.11% |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →AMC Entertainment Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, provides theatrical exhibition, movie screening, food distribution, online ticket booking, and other related services. AMC Entertainment offers movie theaters worldwide.
Read more on AMC →